These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Five-year changes in coronary arteries of medical and surgical patients of the Veterans Administration Randomized Study of Bypass Surgery.
    Author: Kroncke GM, Kosolcharoen P, Clayman JA, Peduzzi PN, Detre K, Takaro T.
    Journal: Circulation; 1988 Sep; 78(3 Pt 2):I144-50. PubMed ID: 3261651.
    Abstract:
    Progression of coronary artery disease was evaluated after 5 years of follow-up in 119 medically and 109 surgically treated randomized patients who adhered to their assigned therapy. Progression was defined as the appearance of a new lesion (greater than or equal to 50% stenosis) or worsening of a preexisting lesion in a coronary artery. Progression occurred in 36% (97 of 268) of the arteries in medical patients, in 38% (35 of 93) of the ungrafted arteries in surgical patients, in 74% (72 of 97) of the arteries with patent grafts at 5 years, and in 63% (29 of 46) of the arteries with closed grafts. After adjustment for the vessel system and the severity of disease at baseline, the risk of progression was three to six times higher in grafted arteries than in ungrafted arteries (p less than 0.01). For grafted arteries, the risk of progression was twice as high in arteries with patent grafts compared with those with closed grafts (p = 0.14). The majority (78%) of the progression in grafted arteries was to 100% occlusion. Proximal and distal progression rates in arteries with patent grafts were 74% and 11%, respectively. In the majority of arteries with closed grafts that progressed, the site of progression could not be determined. Regardless of treatment, the risk of progression was two times higher in the right coronary artery than in the left anterior descending or circumflex arteries. Progression risk was also twice as high in arteries with moderate disease at baseline compared with those with minimal or severe disease.
    [Abstract] [Full Text] [Related] [New Search]